The trademark ALEXI was filed by ParaPharm Development Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on October 10, 2021, and received one opposition filed on January 10, 2022 by EBEWE Pharma Ges.m.b.H. Nfg. KG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 10, 2022
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).